Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus–Related Dementia

E-ISSN： 1532-5415|63|10|2196-2198

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.63, Iss.10, 2015-10, pp. : 2196-2198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 847-854

John Wiley & Sons Inc

Access to resources Recommend Favorite

Guidelines for the Clinical Diagnosis of Diabetes Mellitus–Related Dementia

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 8, 2015-08 ,pp. : 1721-1723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

By Jinnouchi Y. Yamagishi S. Takeuchi M. Ishida S. Jinnouchi Y. Jinnouchi J. Imaizumi T.

Clinical and Experimental Medicine, Vol. 6, Iss. 4, 2006-12 ,pp. : 191-193

Springer Publishing Company

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Aging Collagen

Gerontology, Vol. 44, Iss. 4, 1998-06 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Plasma Concentrations of High-Mobility Group Box Protein 1, Soluble Receptor for Advanced Glycation End-Products and Circulating DNA in Patients with Acute Pancreatitis

Pancreatology, Vol. 9, Iss. 4, 2009-05 ,pp. : 383-391

Karger

Access to resources Recommend Favorite